Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q2 2022 · 10-Q
Revenue$1.53M$1.53M+47.5% vs Q2 2021 Net Income-$4.64M-$4.64MN/M vs Q2 2021 EPS Diluted-$0.59-$0.59N/M vs Q2 2021 Gross Profit$431,000+64.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,109,000N/M Free Cash Flowderived-$3,224,000N/M Margins · derivedGross margin28.2%+2.9 pt vs Q2 2021
Operating margin-305.7%+25.7 pt vs Q2 2021
Net margin-302.8%+35.1 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 8, 2022 · 39 d after period end